Clinical Trials Directory

Trials / Completed

CompletedNCT03305783

The Influence of Cholecystectomy on Secretion of Incretin Hormones

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University Hospital, Gentofte, Copenhagen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The effect of cholecystectomy on postprandial plasma GLP-1 responses (primary endpoint) and glucose metabolism will be evaluated in 30 patients planned to undergo elective laparoscopic cholecystectomy.

Detailed description

This is an observational, parallel-group study in 30 patients with gallstone disease and 10 healthy control subjects. In patients undergoing cholecystectomy a 4h-meal test (liquid mixed meal) will be conducted at baseline (1-2 weeks before surgery) and again within 4 weeks after the cholecystectomy. Healthy subjects will be submitted to a single 4h-meal test. Secondary endpoints include changes in plasma glucose, insulin, glucagon, GIP, PYY, gastrin, CCK, fibroblast growth factor 19 (FGF-19) and bile acids. Furthermore, secondary endpoints include changes in gastric emptying (evaluated by the paracetamol method).

Conditions

Interventions

TypeNameDescription
PROCEDUREcholecystectomyelective cholecystectomy performed due to gallstones, cholecystitis or other non-malignant conditions and therefore done regardless of the protocol of this study.

Timeline

Start date
2017-11-01
Primary completion
2022-03-11
Completion
2022-04-01
First posted
2017-10-10
Last updated
2023-02-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03305783. Inclusion in this directory is not an endorsement.